Optimized cell counting and viability analysis of large, complex A172 glioblastoma cells using the SpectraSlide AP-1 and LUNA-FX7™ automated cell counter
26 Nov 2025Accurate assessment of cell concentration and viability is vital in cancer research, drug development, and immunotherapy, underpinning the evaluation of experimental outcomes and therapeutic efficacy. However, cell models with large and complex morphologies—such as A172 glioblastoma cells—are challenging to analyze with standard viability assays.
In this study, we compared the SpectraSlide® AP-1 and PhotonSlide™ for cell concentration and viability analysis. Using the A172 glioblastoma cell model, we validated the precision and performance of the SpectraSlide® AP-1.
Related products
Request Quote for All Products
SpectraSlide® AP-1
Logos BiosystemsThe SpectraSlide® AP-1, designed for the LUNA-FX7™ automated cell counter, is an all-in-one cell counting slide that simplifies the sample prep process - saving time & money. No pipettes and no stains needed! Simply load a sample directly on the slide, insert into the LUNA-FX7™ and press COUNT.
LUNA-FX7™ Automated Cell Counter
Logos BiosystemsThe LUNA-FX7™ is our most powerful cell counter to date, with unmatched cell counting accuracy, new 1, 3 and 8-chamber slide options, state of the art optics, dual fluorescent and brightfield detection, and precision autofocus. The LUNA-FX7™’s new features such as the Bioprocess mode, Quality Control mode, and the CountWire™ (21 CFR Part 11 compliant) software will help companies and facilities meet and surpass quality and regulatory requirements.